What to do with diabetes therapies when HbA1c lowering is inadequate: add, switch, or continue? A MASTERMIND study

What to do with diabetes therapies when HbA1c lowering is inadequate: add, switch, or continue? A MASTERMIND study

BACKGROUND:It is unclear what to do when people with type 2 diabetes have had no or a limited glycemic response to a recently introduced medication. Intra-individual HbA1c variability can obscure true response. Some guidelines suggest stopping apparently ineffective therapy, but no studies have addr...

Detaylı Bibliyografya
Asıl Yazarlar:	McGovern, A, Dennis, J, Shields, B, Hattersley, A, Pearson, E, Jones, A, Mastermind Consortium
Diğer Yazarlar:	Farmer, A
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	BioMed Central 2019

Benzer Materyaller

What to do with diabetes therapies when HbA1c lowering is inadequate: add, switch, or continue? A MASTERMIND study
Yazar:: Andrew P. McGovern, ve diğerleri
Baskı/Yayın Bilgisi: (2019-04-01)

Should Studies of Diabetes Treatment Stratification Correct for Baseline HbA1c?
Yazar:: Angus G Jones, ve diğerleri
Baskı/Yayın Bilgisi: (2016-01-01)

Costs and treatment pathways for type 2 diabetes in the UK: a Mastermind Cohort study
Yazar:: Eibich, U, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Mastermind ophthalmology
Yazar:: Madhav
Baskı/Yayın Bilgisi: (2007-01-01)

Predicting post one-year durability of glucose-lowering monotherapies in patients with new-onset type 2 diabetes
Yazar:: Agbaje, O, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Fructosamine and HbA1c
Yazar:: Kurumbian Chandran, ve diğerleri
Baskı/Yayın Bilgisi: (2024-02-01)

Oliver heaviside : maverick mastermind of electricity /
Yazar:: 309384 Mahon, Basil
Baskı/Yayın Bilgisi: (2009)

Use of HbA1c in the diagnosis of diabetes.
Yazar:: Farmer, A
Baskı/Yayın Bilgisi: (2012)

Artifactually lowered glycosylated hemoglobin (HbA1c %) in patient with diabetes on dapsone
Yazar:: Amit Rastogi, ve diğerleri
Baskı/Yayın Bilgisi: (2012-01-01)

What are the HbA(1c) thresholds for initiating insulin therapy in people with type 2 diabetes in UK primary care?
Yazar:: Hinton, W, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Predictors of HbA1c treatment response to add-on medication following metformin monotherapy: a population-based cohort study
Yazar:: Wei Ying Tan, ve diğerleri
Baskı/Yayın Bilgisi: (2023-11-01)

HbA1C and diabetes – an overview
Yazar:: S Pathmanathan, ve diğerleri
Baskı/Yayın Bilgisi: (2014-01-01)

A new 6.111 laboratory exercise : Mastermind
Yazar:: Mahn, Nathan A. (Nathan Aaron), 1979-
Baskı/Yayın Bilgisi: (2014)

High-performance liquid chromatography local reference ranges of hemoglobin fractions (HbA, HbA2, and HbF) in detection of hemoglobinopathies in western Kenya
Yazar:: Benard Mutua, ve diğerleri
Baskı/Yayın Bilgisi: (2022-12-01)

The true value of HbA1c as a predictor of diabetic complications: simulations of HbA1c variables.
Yazar:: Marcus Lind, ve diğerleri
Baskı/Yayın Bilgisi: (2009-01-01)

Epstein-Barr virus: the mastermind of immune chaos
Yazar:: Jean de Melo Silva, ve diğerleri
Baskı/Yayın Bilgisi: (2024-02-01)

The Exact Query Complexity of Yes-No Permutation Mastermind
Yazar:: Mourad El Ouali, ve diğerleri
Baskı/Yayın Bilgisi: (2020-04-01)

Mumbai Investigation: The Operatives, Masterminds and Enduring Threat
Yazar:: Rohan Gunaratna
Baskı/Yayın Bilgisi: (2009-01-01)

Selective Phenotyping, Entropy Reduction, and the Mastermind game
Yazar:: Gagneur Julien, ve diğerleri
Baskı/Yayın Bilgisi: (2011-10-01)

The Paradox of Help Seeking in the Entropy Mastermind Game
Yazar:: Nichola Taylor, ve diğerleri
Baskı/Yayın Bilgisi: (2020-09-01)

Liraglutide, a human GLP-1 analogue, lowers HbA(1c) independent of weight loss
Yazar:: Schmidt, W, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Influence of Serum Albumin on HbA1c and HbA1c-Defined Glycemic Status: A Retrospective Study
Yazar:: Xiaojing Feng, ve diğerleri
Baskı/Yayın Bilgisi: (2021-05-01)

Liraglutide Is Associated with Reduced Rates of Hypoglycemic Events Versus Glimepiride When Achieving Target HbA(1c)
Yazar:: Gough, S, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Modelling incremental benefits on complications rates when targeting lower HbA1c levels in people with Type 2 diabetes and cardiovascular disease
Yazar:: Mostafa, SA, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Effects of thyroid status on HbA1c
Yazar:: Sivaranjani Ambalavanan, ve diğerleri
Baskı/Yayın Bilgisi: (2024-11-01)

Drugs affecting HbA1c levels
Yazar:: Ranjit Unnikrishnan, ve diğerleri
Baskı/Yayın Bilgisi: (2012-01-01)

Current Status of HbA1c Biosensors
Yazar:: Hua Lin, ve diğerleri
Baskı/Yayın Bilgisi: (2017-08-01)

Hemoglobin variants detected by hemoglobin A1c (HbA1c) analysis and the effects on HbA1c measurements.
Yazar:: Nasir, N.M., ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Sleep characteristics and HbA1c in patients with type 2 diabetes on glucose-lowering medication
Yazar:: Christian Benedict
Baskı/Yayın Bilgisi: (2020-04-01)

Therapies for type 2 diabetes: lowering HbA1c and associated cardiovascular risk factors
Yazar:: Kurukulasuriya L Romayne, ve diğerleri
Baskı/Yayın Bilgisi: (2010-08-01)

Death of Bahrun Naim : Mastermind of Terror in Southeast Asia
Yazar:: Gunaratna, Rohan
Baskı/Yayın Bilgisi: (2018)

“Evil Mastermind” in the framework of a verbally modeled reality
Yazar:: Oleksandr Kolesnyk, ve diğerleri
Baskı/Yayın Bilgisi: (2022-12-01)

Choice of HbA1c threshold for identifying individuals at high risk of type 2 diabetes and implications for diabetes prevention programmes: a cohort study
Yazar:: Lauren R. Rodgers, ve diğerleri
Baskı/Yayın Bilgisi: (2021-08-01)

Recent UK type 2 diabetes treatment guidance represents a near whole population indication for SGLT2-inhibitor therapy
Yazar:: Katherine G. Young, ve diğerleri
Baskı/Yayın Bilgisi: (2023-11-01)

Glycated haemoglobin - when can we trust it? Analysis of factors affecting the HbA1c level
Yazar:: Marcin Lewicki, ve diğerleri
Baskı/Yayın Bilgisi: (2018-12-01)

Glycated haemoglobin - when can we trust it? Analysis of factors affecting the HbA1c level
Yazar:: Marcin Lewicki, ve diğerleri
Baskı/Yayın Bilgisi: (2018-12-01)

Haemoglobin types and variant interference with HbA1c and its association with uncontrolled HbA1c in type 2 diabetes mellitus
Yazar:: Joseph Malaba, ve diğerleri
Baskı/Yayın Bilgisi: (2024-11-01)

Symposium 3: HbA1c: Are HbA1c determinations reliable enough today in Argentina to adopt them as diagnostic criteria?
Yazar:: Carla Lucarelli
Baskı/Yayın Bilgisi: (2022-09-01)

Understanding the relationship between the frequency of HbA1c monitoring, HbA1c changes over time, and the achievement of targets: a retrospective cohort study
Yazar:: Elton Mukonda, ve diğerleri
Baskı/Yayın Bilgisi: (2025-01-01)

HbA1c in patients with glioblastomas - a preliminary study
Yazar:: D. Orešković, ve diğerleri
Baskı/Yayın Bilgisi: (2022-01-01)